Roth Capital initiated coverage on Lydall, Inc. (NYSE: LDL) with a Buy rating. The price target for Lydall is set to $58. Lydall shares closed at $49.95 on Tuesday.
Analysts at B. Riley initiated coverage of Points International...
While Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) have appreciated 38 percent since the favorable U.S. Fanapt IP ruling on August 25, Jefferies’ Matthew J. Andrews believes that there could be potential for long-term upside to the...
CANONSBURG (dpa-AFX) - Chembio Diagnostics Inc. (CEMI) has been awarded up
to $13.2 million U.S. Government contract for the development and
commercialization of the company's rapid POC Zika test and Zika-related
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Vanda Pharmaceuticals (VNDA):